Spyre Therapeutics ($SYRE): 13D holder update
Fairmount Funds Management: 9.99%, unchanged (about $814M)
Counts convertible securities
SEC Schedule 13D/A · filed Oct 9
#ActivistInvesting #Stocks
Visit for more info: www.elixstocks.com
Educational only. Not investment advice.
